
Douglas D. Watts
Examiner (ID: 9275)
| Most Active Art Unit | 3204 |
| Art Unit(s) | 3724, 2899, 3101, 3103, 3727, 2902, 3204, 3203, 3105 |
| Total Applications | 2654 |
| Issued Applications | 2350 |
| Pending Applications | 81 |
| Abandoned Applications | 222 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3938211
[patent_doc_number] => 05997872
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/993118
[patent_app_country] => US
[patent_app_date] => 1997-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12518
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/997/05997872.pdf
[firstpage_image] =>[orig_patent_app_number] => 993118
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/993118 | Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof | Dec 16, 1997 | Issued |
Array
(
[id] => 3922720
[patent_doc_number] => 05914249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-22
[patent_title] => 'Cell-cycle phosphoproteins'
[patent_app_type] => 1
[patent_app_number] => 8/986217
[patent_app_country] => US
[patent_app_date] => 1997-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22342
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/914/05914249.pdf
[firstpage_image] =>[orig_patent_app_number] => 986217
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/986217 | Cell-cycle phosphoproteins | Dec 4, 1997 | Issued |
| 08/979742 | MOUSE TELMOERASE REVERSE TRANSCRIPTASE | Nov 25, 1997 | Abandoned |
Array
(
[id] => 4140579
[patent_doc_number] => 06030809
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-29
[patent_title] => 'Glutathione S-transferase'
[patent_app_type] => 1
[patent_app_number] => 8/978174
[patent_app_country] => US
[patent_app_date] => 1997-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19696
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/030/06030809.pdf
[firstpage_image] =>[orig_patent_app_number] => 978174
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/978174 | Glutathione S-transferase | Nov 24, 1997 | Issued |
Array
(
[id] => 4094190
[patent_doc_number] => 06048528
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'Monoclonal antibody for diagnostic and therapeutic use in ovarian cancer'
[patent_app_type] => 1
[patent_app_number] => 8/977373
[patent_app_country] => US
[patent_app_date] => 1997-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 26
[patent_no_of_words] => 4853
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048528.pdf
[firstpage_image] =>[orig_patent_app_number] => 977373
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/977373 | Monoclonal antibody for diagnostic and therapeutic use in ovarian cancer | Nov 23, 1997 | Issued |
| 08/913420 | ANTIBODY SPECIFIC FOR ARGINASE ORIGINATING IN LIVER AND USE OF THE SAME | Nov 19, 1997 | Abandoned |
Array
(
[id] => 4240209
[patent_doc_number] => 06166178
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Telomerase catalytic subunit'
[patent_app_type] => 1
[patent_app_number] => 8/974549
[patent_app_country] => US
[patent_app_date] => 1997-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 103
[patent_figures_cnt] => 128
[patent_no_of_words] => 209095
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/166/06166178.pdf
[firstpage_image] =>[orig_patent_app_number] => 974549
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/974549 | Telomerase catalytic subunit | Nov 18, 1997 | Issued |
Array
(
[id] => 3992768
[patent_doc_number] => 05985658
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Calmodulin-based cell separation technique'
[patent_app_type] => 1
[patent_app_number] => 8/970363
[patent_app_country] => US
[patent_app_date] => 1997-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 22
[patent_no_of_words] => 7960
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985658.pdf
[firstpage_image] =>[orig_patent_app_number] => 970363
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/970363 | Calmodulin-based cell separation technique | Nov 13, 1997 | Issued |
Array
(
[id] => 4153905
[patent_doc_number] => 06114128
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-05
[patent_title] => 'Method and kit for predicting the therapeutic response of a drug against a malignant tumor'
[patent_app_type] => 1
[patent_app_number] => 8/952140
[patent_app_country] => US
[patent_app_date] => 1997-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4476
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/114/06114128.pdf
[firstpage_image] =>[orig_patent_app_number] => 952140
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/952140 | Method and kit for predicting the therapeutic response of a drug against a malignant tumor | Nov 9, 1997 | Issued |
Array
(
[id] => 4050225
[patent_doc_number] => 05932444
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Vacuolar atpase subunit AC45'
[patent_app_type] => 1
[patent_app_number] => 8/959011
[patent_app_country] => US
[patent_app_date] => 1997-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20448
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932444.pdf
[firstpage_image] =>[orig_patent_app_number] => 959011
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/959011 | Vacuolar atpase subunit AC45 | Oct 27, 1997 | Issued |
| 08/836129 | APOPTOSIS-ASSOCIATED GENE | Oct 23, 1997 | Abandoned |
| 08/945287 | CANCER ASSAY | Oct 16, 1997 | Abandoned |
Array
(
[id] => 4192327
[patent_doc_number] => 06130201
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-10
[patent_title] => 'Modulation of BCL-2 phosphorylation'
[patent_app_type] => 1
[patent_app_number] => 8/929436
[patent_app_country] => US
[patent_app_date] => 1997-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6276
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/130/06130201.pdf
[firstpage_image] =>[orig_patent_app_number] => 929436
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/929436 | Modulation of BCL-2 phosphorylation | Sep 14, 1997 | Issued |
Array
(
[id] => 4167150
[patent_doc_number] => 06140065
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Methods for diagnosing benign prostatic diseases and prostatic adenocarcinoma using an algorithm'
[patent_app_type] => 1
[patent_app_number] => 8/924667
[patent_app_country] => US
[patent_app_date] => 1997-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4033
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/140/06140065.pdf
[firstpage_image] =>[orig_patent_app_number] => 924667
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/924667 | Methods for diagnosing benign prostatic diseases and prostatic adenocarcinoma using an algorithm | Sep 4, 1997 | Issued |
Array
(
[id] => 4091942
[patent_doc_number] => 06133416
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Inhibition of cell growth by an anti-proliferative factor'
[patent_app_type] => 1
[patent_app_number] => 8/918712
[patent_app_country] => US
[patent_app_date] => 1997-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 26502
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133416.pdf
[firstpage_image] =>[orig_patent_app_number] => 918712
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/918712 | Inhibition of cell growth by an anti-proliferative factor | Aug 21, 1997 | Issued |
Array
(
[id] => 4366857
[patent_doc_number] => 06287802
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'EXT2 gene'
[patent_app_type] => 1
[patent_app_number] => 8/915337
[patent_app_country] => US
[patent_app_date] => 1997-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18074
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/287/06287802.pdf
[firstpage_image] =>[orig_patent_app_number] => 915337
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/915337 | EXT2 gene | Aug 20, 1997 | Issued |
Array
(
[id] => 3920743
[patent_doc_number] => 05951985
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-14
[patent_title] => 'Tumor associated epitope'
[patent_app_type] => 1
[patent_app_number] => 8/960128
[patent_app_country] => US
[patent_app_date] => 1997-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6003
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/951/05951985.pdf
[firstpage_image] =>[orig_patent_app_number] => 960128
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/960128 | Tumor associated epitope | Aug 18, 1997 | Issued |
Array
(
[id] => 4100382
[patent_doc_number] => 06100058
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-08
[patent_title] => 'Gap12 genes and their uses'
[patent_app_type] => 1
[patent_app_number] => 8/909954
[patent_app_country] => US
[patent_app_date] => 1997-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 14921
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/100/06100058.pdf
[firstpage_image] =>[orig_patent_app_number] => 909954
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/909954 | Gap12 genes and their uses | Aug 11, 1997 | Issued |
| 08/860232 | IN VIVO ACTIVATION OF TUMOR-SPECIFIC CYTOTOXIC T CELLS | Aug 7, 1997 | Abandoned |
Array
(
[id] => 4129498
[patent_doc_number] => 06120995
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => 'Compositions that specifically bind to colorectal cancer cells and methods of using the same'
[patent_app_type] => 1
[patent_app_number] => 8/908643
[patent_app_country] => US
[patent_app_date] => 1997-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 44872
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/120/06120995.pdf
[firstpage_image] =>[orig_patent_app_number] => 908643
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/908643 | Compositions that specifically bind to colorectal cancer cells and methods of using the same | Aug 6, 1997 | Issued |